Queen's University Belfast and Fusion Antibodies
Lead Participant:
Queen's University of Belfast
Abstract
To develop new innovative processes to create a novel platform technology for the generation and maturation of fully human antibodies that can be rapidly progressed by clients into clinical development.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| Queen's University of Belfast, United Kingdom | £232,264 | £ 155,617 |
People |
ORCID iD |
| Unknown Unknown Unknown (Project Manager) |